Table 2 Use of biologic agents after withdrawal of infliximab therapy
New biologic therapy | Reason for withdrawal | Total | ||
|---|---|---|---|---|
Lack of efficacy | Patient request | Safety issues | ||
None | 24 | 3 | 44 | 71 |
Adalinumab | 10 | 23 | 3 | 36 |
Etanercept | 6 | 4 | 8 | 18 |
Rituximab | 8 | 0 | 1 | 9 |
Abatacept | 4 | 0 | 4 | 8 |
Total | 52 | 30 | 60 | 142 |